Prothena Corp Public (PRTA) Cash & Equivalents Growth (1y) (2013 - 2026)
Prothena Corp Public (PRTA) Cash & Equivalents Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 23.81% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 71.81% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Prothena Corp Public | 471.02 Mn | 141.56 Mn | - | -21.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.17% |
| Dec 31, 2025 | -34.76% |
| Sep 30, 2025 | -36.29% |
| Jun 30, 2025 | -34.16% |
| Mar 31, 2025 | -23.53% |
| Dec 31, 2024 | -23.83% |
| Sep 30, 2024 | -22.60% |
| Jun 30, 2024 | -14.41% |
| Mar 31, 2024 | -20.35% |
| Dec 31, 2023 | -12.89% |
| Sep 30, 2023 | 35.36% |
| Jun 30, 2023 | 29.54% |
| Mar 31, 2023 | 26.37% |
| Dec 31, 2022 | 22.68% |
| Sep 30, 2022 | -17.41% |
| Jun 30, 2022 | 27.25% |
| Mar 31, 2022 | 58.31% |
| Dec 31, 2021 | 96.05% |
| Sep 30, 2021 | 90.80% |
| Jun 30, 2021 | 19.73% |